VCP and prostate carcinoma: Additionally, clinical studies have identified a correlation between elevated VCP expression and the progression, prognosis, and metastatic potential of esophageal carcinoma (34), colorectal carcinoma (35), prostate cancer (36), non-small cell lung carcinoma (37), and pancreatic cancer.